Citation Impact
Citing Papers
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Rodent-borne diseases and their risks for public health
2009 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
Indications for referral and assessment in adultliver transplantation: a clinical guideline
1999
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.
1996
Differential Serum Levels of Eosinophilic Eotaxins in Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Autoimmune Hepatitis
2013 StandoutNobel
Urban Zoonoses Caused by Bartonella , Coxiella , Ehrlichia , and Rickettsia Species
2001
Critical review: vegetables and fruit in the prevention of chronic diseases
2012 Standout
The Survival Benefit of Liver Transplantation
2005 Standout
Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis
2013
Analysis of 388 cases of primary sclerosing cholangitis in JapanPresence of a subgroup without pancreatic involvement in older patients
2004
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis
2012
Accumulation of macrophages in primary sclerosing cholangitis
2001
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
2000 Standout
Primary sclerosing cholangitis: Refinement and validation of survival models
1992
The Use of Fresh Whole Blood in Massive Transfusion
2006
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Pathobiology of Infection in Prosthetic Devices
1988
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Ulcerative Colitis
2011 Standout
Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms
2007
Burden of liver diseases in the world
2018 Standout
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
2001 Standout
Zoonoses in Solid-Organ and Hematopoietic Stem Cell Transplant Recipients
2007
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Inflammatory myofibroblastic tumours: where are we now?
2007 Standout
Macrophages: Master Regulators of Inflammation and Fibrosis
2010 Standout
Primary Sclerosing Cholangitis
2005
Extraintestinal manifestations in inflammatory bowel disease
2005
An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction
2009 Standout
Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease
2006
Epidemiology and risk factors for IBD
2015 Standout
IgG4-Related Disease
2012 Standout
Increased Plasma and Platelet to Red Blood Cell Ratios Improves Outcome in 466 Massively Transfused Civilian Trauma Patients
2008 Standout
Liver transplantation
2000
Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy
2008 Standout
Inflammatory Bowel Disease and Smoking
2004
Clinical features and management of primary sclerosing Cholangitis
2008
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential
1995
CAN GRAFT ENDOTHELIAL CELLS INITIATE A HOST ANTI-GRAFT IMMUNE RESPONSE?1
1996
Model for end-stage liver disease (MELD) and allocation of donor livers
2003 Standout
Is There A Role for Liver Biopsy in Primary Sclerosing Cholangitis?
2003
Inflammatory Bowel Disease
2002 Standout
MELD and PELD: Application of survival models to liver allocation
2001
Infective endocarditis
1995
The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis
1997
PRIMARY BILIARY CIRRHOSIS AND PRIMARY SCLEROSING CHOLANGITIS
1999
Global burden of liver disease: 2023 update
2023 Standout
Ulcerative colitis
2016 Standout
YOUTH
2006
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
2004
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Distinct clinicopathological entity ‘autoimmune pancreatitis‐associated sclerosing cholangitis’
2005
IgG4-related disease
2014 Standout
Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis
2007 Standout
Oral budesonide in the treatment of primary sclerosing cholangitis
2000
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
Primary sclerosing cholangitis
1999
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a united states community
2003
Characterization, Outcome, and Prognosis in 273 Patients with Primary Sclerosing Cholangitis: A Single Center Study
2006
Steroid-Responsive (Autoimmune?) Sclerosing Cholangitis
2005
Infective endocarditis
2004 Standout
Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis
1998
Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study
2002
Severe Cholestasis Induced by Cholic Acid Feeding in Knockout Mice of Sister of P–Glycoprotein
2003
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction
2009 Standout
Primary sclerosing cholangitis – a comprehensive review
2017
International Clinical Recommendations on Scar Management
2002 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis
2020 StandoutNobel
Design principles for orally bioavailable drugs
1996
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
1997 Standout
Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.
2013
Autoimmune pancreatocholangitis: A series of ten patients
2006
Nationwide survey for primary sclerosing cholangitis and IgG 4‐related sclerosing cholangitis in J apan
2013
Molecular Properties That Influence the Oral Bioavailability of Drug Candidates
2002 Standout
Recent advances in the development of farnesoid X receptor agonists.
2015
Prediction of Drug Absorption Using Multivariate Statistics
2000 Standout
Hepatic and extrahepatic malignancies in primary sclerosing cholangitis
2002
Course of Crohn's disease after allogeneic marrow transplantation
1998
Inflammatory Bowel Disease
2010 Standout
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
2012 Standout
Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis
1993
Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
2013
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Microbial Biofilms: from Ecology to Molecular Genetics
2000 Standout
Physicochemical and drug-delivery considerations for oral drug bioavailability
1996
Endocarditis Due to Rare and Fastidious Bacteria
2001 Standout
Laser ablation of burns: Initial clinical trial
1999
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
Classification of chronic hepatitis: Diagnosis, grading and staging
1994 Standout
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Works of Ellen B. Hunter being referenced
Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis
1989
Physicochemical Determinants in Hepatic Extraction of Small Peptides
1990
Safety of the Blood Supply Surrogate Testing and Transmission of Hepatitis C in Patients After Massive Transfusion
1994
HUMAN EHRLICHIOSIS IN A LIVER TRANSPLANT RECIPIENT
1995
HUMAN EHRLICHIOSIS IN A LIVER TRANSPLANT RECIPIENT
1995
Endocarditis and Infections of Intravascular Devices Due to Eikenella corrodens
1986